Clinical trial
"Effect of Perioperative and Short-Term Apixaban Therapy on Arteriovenous Fistula Maturation in Patients With End-Stage Renal Disease: A Randomized Controlled Trial"
NCT07559942 is registered in ClinicalTrials.gov with Combined military hospital lahore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Effect of Perioperative and Short-Term Apixaban Therapy on Arteriovenous Fistula Maturation in Patients With End-Stage Renal Disease: A Randomized Controlled Trial"
- Lead sponsor
- Combined military hospital lahore
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 1, 2026
- Completion date
- August 31, 2026
- Enrollment
- 190 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arteriovenous fistula, arteriovenous fistula occlusion, direct oral anticoagulants (doacs), endstage renal disease